Page results
-
Outcome of National Institute for Health and Care Excellence (NICE) Technology Appraisal for Exagamglogene autotemcel (Exa-cel) for treating transfusion- dependent beta thalassaemia [ID4015] in individuals 12 years and over.
-
This page is for patients who have been referred on a suspected cancer pathway.
-
NHS England has published a proposed interim specification for the new services for children and young people experiencing gender dysphoria.
-
UCLH is to host to a new collaboration researching patient safety, after being awarded £3million in funding.
-
Researchers at UCLH and Imperial College Healthcare NHS Trust are to trial a new weight loss treatment which involves reducing blood supply to part of the stomach.
-
It’s a clean sweep for our nominees at this year’s RCN Nursing Awards. Congratulations to winners Jo Hargroves, Robert Vicente and Susie Lagrata!
-
The Royal Parks Half Marathon makes a spectacular return this weekend.
-
UCLH continues to achieve excellent results in the National Inpatient Survey. In 2021 patients rated their overall care as 8.5 out of 10 which is the top score in London and the second best in the Shelford Group.
-
Information on contrast agents for X-ray, fluoroscopy, CT and angiography examinations at NHNN
-
The iconic run has returned to its regular time of the year, following two years’ disruption following the pandemic and will take place on Sunday 2 October 2022. We are lucky enough to have five people running for UCLH Charity. The money they raise will help us support patients, staff and research at UCLH.
File results
-
FOI/2024/0108 - Clinical letters/ EPR, PAS, patient portal systems, hybrid mail contract
-
FOI/2024/0112 - Fertility treatment in 2021
-
FOI/2024/0116 - Patient treatment due to noise levels of the London Underground
-
FOI/2024/0121 - Migraine treatments
-
FOI/2024/0126 - Ophthalmology RTT pathway
-
FOI/2024/0128 - Post mortem cardiac device interrogation
-
FOI/2024/0129 - Nursing associate and anaesthesia associate staffing
-
FOI/2024/0131 - Alpha-1 Proteinase-Inhibitor (AAT) purchased in 2023
-
FOI/2024/0132 - Cancer patients diagnosed in A&E
-
FOI/2024/0133 - Non-Emergency Patient Transport Services (NEPTS)